Tag: Glycoprotein iib iiia inhibitor

Tirofiban is a potent and fast-acting medication, and its classification is often misunderstood. In fact, it is an antiplatelet medication, not an anticoagulant, with a very specific mechanism of action. This article will clarify how is tirofiban an anticoagulant or antiplatelet and delve into its distinct role in preventing blood clots.

Before its discontinuation in 2019, abciximab was a groundbreaking antiplatelet agent widely used in cardiology to prevent thrombotic complications during percutaneous coronary intervention (PCI). A specific question that arises is **what category is abciximab**, and the answer reveals its unique pharmacological nature and historical significance.